GANIRELIX
Total Payments
$11,488
Transactions
410
Doctors
187
Companies
2
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2019 | $1,885 | 106 | 81 |
| 2018 | $1,282 | 78 | 44 |
| 2017 | $8,322 | 226 | 104 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,564 | 409 | 57.1% |
| Unspecified | $4,925 | 1 | 42.9% |
Payments by Type
General
$6,564
409 transactions
Research
$4,925
1 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| Efficacy of Recombinant FSH,GnRH Antagonist Protocol with and without LH Adjunct and GnRH agonist trigger for Egg Bank Donation. | Merck Sharp & Dohme Corporation | $4,925 | 0 |
Top Doctors Receiving Payments for GANIRELIX — Page 8
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| , D.O | Urology | Langhorne, PA | $13.78 | 1 |
| , M.D | Family Medicine | Springfield, OH | $13.67 | 1 |
| , MD | Obstetrics & Gynecology | Brighton, MI | $13.07 | 1 |
| , M.D | Reproductive Endocrinology | Bedford, TX | $12.94 | 1 |
| , MD | Reproductive Endocrinology | Farmington, CT | $12.56 | 1 |
| , M.D | Gynecology | Phoenix, AZ | $12.23 | 1 |
| , MD | Reproductive Endocrinology | Ypsilanti, MI | $12.18 | 1 |
| Richard Dickey | — | Mandeville, LA | $11.51 | 1 |
| , MD | Reproductive Endocrinology | Latham, NY | $11.51 | 1 |
| , M.D | Reproductive Endocrinology | Mandeville, LA | $11.51 | 1 |
| , MD | Reproductive Endocrinology | Las Vegas, NV | $11.40 | 1 |
| , M.D | Reproductive Endocrinology | Las Vegas, NV | $8.43 | 1 |
| , M.D | Reproductive Endocrinology | Warrenville, IL | $8.27 | 1 |
Ad
Manufacturing Companies
- Merck Sharp & Dohme Corporation $11,361
- Ferring Pharmaceuticals Inc. $127.23
Product Information
- Type Drug
- Total Payments $11,488
- Total Doctors 187
- Transactions 410
About GANIRELIX
GANIRELIX is a drug associated with $11,488 in payments to 187 healthcare providers, recorded across 410 transactions in the CMS Open Payments database. The primary manufacturer is Merck Sharp & Dohme Corporation.
Payment data is available from 2017 to 2019. In 2019, $1,885 was paid across 106 transactions to 81 doctors.
The most common payment nature for GANIRELIX is "Food and Beverage" ($6,564, 57.1% of total).
GANIRELIX is associated with 1 research study, including "Efficacy of Recombinant FSH,GnRH Antagonist Protocol with and without LH Adjunct and GnRH agonist trigger for Egg Bank Donation." ($4,925).